article · International Journal of Pharmacology and Toxicology
Background: An acute toxicity study evaluates the harmful effects of substances absorbed through any route and utilizes parameters like LD50 to assess toxicity. While mortality is commonly used as a primary endpoint, considering signs of toxicity is crucial as they indicate adverse effects on internal organs, which can lead to lasting damage or death. Objectives: This study compares the acute toxicity of three medicinal plants with anticancer properties, highlighting the importance of understanding their safety profiles despite their therapeutic potential. Methods: The acute toxicity of methanol extracts from Curcuma longa rhizome, Datura metel fruits, and Phoenix dactylifera fruits in rats were compared to determine the safest of the three plant extracts. A new modified method was employed to estimate the Lowest Observed Adverse Effect Level (LOAEL) and the No Observed Adverse Effect Level (NOAEL). Each dose level involved three (3) rats, with a default dose progression of log 3.2 if the animal dies or a sign of toxicity is observed. Results: While no mortality occurred at a dose of 5000 mg/kg body weight for any extract, signs of toxicity were observed. Histological changes were noted in animals without apparent signs of toxicity, challenging the assumption that LD50 values exceeding 5000 mg/kg body weight indicate non-toxicity. Threshold dose analysis revealed differences in toxicity among the extracts. Curcuma longa rhizome methanol extract demonstrated the highest safety margin. Conclusion: These findings emphasize the importance of considering signs of toxicity alongside mortality in acute toxicity assessments.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.14419/vf8xdc66
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.